Brief: Ensysce Biosciences Reports Q3 Net Loss Of $17.2 Mln Vs. Net Income Of $1.6 Mln In Q3 2020
Nov 15 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND RECENT CORPORATE UPDATES
* ENSYSCE BIOSCIENCES INC - NET LOSS FOR Q3 OF 2021 WAS
$17.2
MILLION COMPARED TO NET INCOME OF $1.6 MILLION FOR SAME PERIOD
IN 2020
Source text for Eikon: ID:nGNXb7pFVh
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing